Breast Cancer (Issue 1) | Special Reports

Biomarker-Driven Trial of Novel Topo-1 Inhibitor Debuted

December 18, 2014

Clinical Articles

An international team of investigators is evaluating the novel topoisomerase-1 inhibitor etirinotecan pegol in patients with metastatic breast cancer, and at the same time evaluating target-specific biomarkers in CTCs.

Anti-Androgen Not for Male Cancers Alone

December 18, 2014

Clinical Articles

A potential pathogenic role for the androgen receptor (AR) exists for some breast cancer (BC) subtypes according to 2 new studies presented at the San Antonio Breast Cancer Symposium (SABCS) 2014.

Trials Seek Optimal nab-Paclitaxel Regimen for First-Line Use in TNMBC

December 18, 2014

Clinical Articles

An ongoing clinical trial will determine whether the addition of weekly nab-paclitaxel to gemcitabine or carboplatin improves PFS versus the gemcitabine-carboplatin doublet as first-line therapy for patients with metastatic TNBC.